[Breast cancer and obesity, a dangerous relation].
Obesity is associated with different cancers including breast cancer, whose incidence is increased in postmenopausal women. It has an adverse impact on the prognosis of the patients, regardless of their menopausal status. The fact of receiving a systemic adjuvant therapy does not neutralize the prognostic role of obesity. Moderate weight loss after cancer diagnosis could improve the outcome of the patients, while a weight gain during treatment seems without significant effect. Currently available data are still too incomplete to justify systematic programs to lose weight with an oncologic therapeutic aim. However, it is worth to encourage and support our patients to have an optimal diet, physical activity, and to lose weight as promotion of general health.
Centre pluridisciplinaire d'oncologie, CHUV, 1011 Lausanne. khalil.zaman@chuv.ch
Khalil
K
Zaman
Alexandre
A
Bodmer
François
F
Pralong
Monica
M
Castiglione-Gertsch
D024221:Antineoplastic Protocols / Q000592:standards; D001835:Body Weight / Q000502:physiology; D001943:Breast Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D005260:Female; D006801:Humans; D008954:Models, Biological; D009765:Obesity / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology; D011379:Prognosis; D012307:Risk Factors